Dr. Lal PathLabs Ltd
BSE:539524

Watchlist Manager
Dr. Lal PathLabs Ltd Logo
Dr. Lal PathLabs Ltd
BSE:539524
Watchlist
Price: 1 368.1 INR -2.1% Market Closed
Market Cap: ₹113.9B

EV/IC

15.3
Current
3%
Cheaper
vs 3-y average of 15.8

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
15.3
=
Enterprise Value
₹225.1B
/
Invested Capital
₹14.3B

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
15.3
=
Enterprise Value
₹225.1B
/
Invested Capital
₹14.3B

Valuation Scenarios

Dr. Lal PathLabs Ltd is trading below its 3-year average

If EV/IC returns to its 3-Year Average (15.8), the stock would be worth ₹1 414.72 (3% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-85%
Maximum Upside
+9%
Average Downside
34%
Scenario EV/IC Value Implied Price Upside/Downside
Current Multiple 15.3 ₹1 368.1
0%
3-Year Average 15.8 ₹1 414.72
+3%
5-Year Average 16.8 ₹1 497.19
+9%
Industry Average 5.7 ₹510.78
-63%
Country Average 2.3 ₹202.6
-85%

Forward EV/IC
Today’s price vs future invested capital

Not enough data available to calculate forward EV/IC

Peer Comparison

All Multiples
EV/IC
P/E
All Countries
Close

Market Distribution

Higher than 84% of companies in India
Percentile
84th
Based on 2 828 companies
84th percentile
7.2
Low
0 — 1.3
Typical Range
1.3 — 4.2
High
4.2 —
Distribution Statistics
India
Min 0
30th Percentile 1.3
Median 2.3
70th Percentile 4.2
Max 4 185.7

Dr. Lal PathLabs Ltd
Glance View

Market Cap
113.9B INR
Industry
Health Care

Dr. Lal PathLabs Ltd. traces its origins back to 1949 when Dr. S.K. Lal, a committed professional with a vision for transforming patient care in India, laid its foundation. With a single laboratory in Delhi, the firm embarked on a journey to make diagnostic services accessible, accurate, and affordable for millions. Over the years, the company's dedication to eking out a niche in the healthcare sector was epitomized by its expansive network that bridges urban and rural India. As of today, it boasts a robust footprint with thousands of patient service centers and diagnostic facilities, enabling them to deliver high-quality pathology services across the length and breadth of the country. This network is instrumental in addressing the diagnostic needs of individuals, bringing specialized tests and healthcare packages within arm's reach of the populace, thus weaving healthcare into the fabric of everyday life. Financially, Dr. Lal PathLabs Ltd. thrives on a well-oiled operational model that deftly balances reach, scalability, and innovation. The company's revenue streams are predominantly anchored in routine and specialized pathology tests, ranging from basic blood tests to complex genetic analyses. By deploying state-of-the-art technology and adhering to high standards of quality control, the firm ensures precision, which instills trust and sustains its business growth. Additionally, strategic collaborations with hospitals, corporate health programs, and wellness initiatives further bolster its financial health. This integrative approach, coupled with a commitment to swallowing costs through operational efficiencies, allows Dr. Lal PathLabs to maintain competitive pricing strategies, thus ensuring sustainable profitability while continuing to innovate in the face of an ever-evolving healthcare landscape.

LALPATHLAB Intrinsic Value
1 047 INR
Overvaluation 23%
Intrinsic Value
Price ₹1 368.1
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett